Urinary steroid metabolome, blood pressure and long-term renal outcomes in autosomal dominant polycystic kidney disease: a cross-sectional and 18-year longitudinal analysis of the SUISSE ADPKD cohort
Research Connections · 2026-11-10
DOI: 10.1093/rescon/vmag210 ↗Abstract
Abstract Background and hypothesis Hypertension occurs early in autosomal dominant polycystic kidney disease (ADPKD) and is linked to activation of the renin–angiotensin–aldosterone system. Whether the urinary steroid metabolome—reflecting pre-receptor glucocorticoid and mineralocorticoid metabolism—differs from health, relates to blood pressure, or predicts long-term progression is unknown. Methods We studied 62 untreated patients with ADPKD from the single-centre SUISSE cohort and 20 healthy volunteers. The 24-hour urinary steroid metabolome was quantified by gas chromatography–mass spectrometry, indexing 11β-hydroxysteroid dehydrogenase activity (cortisol/cortisone, F/E), cortisol production and relative aldosterone excretion. Baseline values were linked to a registry (median follow-up 18.3 years). The primary outcome was the rate of decline in estimated glomerular filtration rate (eGFR; CKD-EPI 2021, linear mixed-effects models); secondary outcomes were total kidney volume (TKV) growth, a composite kidney end point (end-stage kidney disease [ESKD] or eGFR halving) and incident hypertension. Associations (per standard deviation) were adjusted for baseline eGFR, baseline TKV, age and sex. Results Steroid differences from controls were sex-specific: the cortisol/cortisone ratio (F/E) was lower in ADPKD men (0.76 versus 1.08; p = 0.003) and relative aldosterone excretion higher in women (p = 0.005). Over a median of 18.3 years (median TKV growth 5.9%/year), a higher baseline F/E was associated with faster kidney growth (adjusted β = +0.88%/year per standard deviation; p = 0.007; false-discovery rate q = 0.03). In contrast, no steroid index modified the rate of eGFR decline (median slope −2.3 mL/min/1.73 m²/year), nor predicted the composite kidney end point or incident hypertension after adjustment; crude inverse steroid–blood-pressure associations disappeared after sex adjustment, and creatinine-corrected salt intake predicted no outcome. Conclusions In ADPKD the urinary steroid metabolome differs from health in a sex-specific manner, and a higher cortisol/cortisone ratio is associated with faster kidney growth—an exploratory, hypothesis-generating signal. It does not, however, predict the rate of GFR decline, and sex is the dominant determinant of the steroid–outcome relationship.
EUVIMED